Why the study?
Does uterine artery embolization using N-butyl-2-cyanoacrylate improve clinical success in patients with uterine artery pseudoaneurysm and postpartum hemorrhage?
Does uterine artery embolization using N-butyl-2-cyanoacrylate improve clinical success in patients with uterine artery pseudoaneurysm and postpartum hemorrhage?
Uterine artery embolization using N-butyl-2-cyanoacrylate is a safe and highly effective treatment for uterine artery pseudoaneurysm in patients with postpartum hemorrhage.
May support NBCA glue as an option for UAP embolization; hypothesis-generating case series leaves comparative efficacy and safety open.
In this case series, we evaluated the efficacy and safety of uterine artery embolization (UAE) using N-butyl- 2-cyanoacrylate (NBCA)/glue for the treatment of uterine artery pseudoaneurysm (UAP). Here, we report 8 patients with uterine artery pseudoaneurysm, who underwent UAE using NBCA/glue. Angiograms and medical records were retrospectively analyzed to determine the technical success, clinical success, complications, average procedure time, the average duration of hospital stay after UAE. All patients were presented with secondary postpartum hemorrhage with hemodynamic instability. The technical and clinical success rates were 100%, respectively. The average procedure time was 21minutes and the average duration of hospital stay was 2.2 days. We did not encounter any major complications. Two patients following UAE were naturally conceived and delivered by repeat LSCS. UAE using NBCA/glue is a safe and effective treatment option for UAP in both hemodynamically stable and unstable patients.
No takes yet. Share an insight, caveat, or question.
Pothula et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: